Fedratinib hydrochloride
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Inrebic is a prescription oral capsule containing 100 mg of fedratinib hydrochloride, used for certain blood disorders. Manufactured by Celgene Corporation under NDA212327, it was approved in August 2019. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Fedratinib hydrochloride
Access the FDA dataset for Fedratinib hydrochloride — ANDA 212327 submitted by Mylan Institutional LLC
Modified Apr 29, 2026